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Abstract 
 
Acute or long-term energy deficit in lean or obese rodents or humans stimulates food intake 
or appetite and reduces metabolic rate or energy expenditure. These changes contribute to 
weight regain in post-obese animals and humans. Some studies show that the reduction in 
metabolic rate with energy deficit in overweight people is transient. Energy restriction has 
been shown in some but not all studies to reduce physical activity, and this may represent an 
additional energy-conserving adaptation. Energy restriction up-regulates expression of the 
orexigenic neuropeptide Y, agouti related peptide and opioids and down-regulates that of the 
anorexigenic alpha-melanocyte stimulating hormone or its precursor pro-opioomelanocortin 
and the co-expressed cocaine and amphetamine-regulated transcript in the arcuate nucleus 
of the hypothalamus. Recapitulating these hypothalamic changes in sated animals mimics the 
effects of energy deficit, namely increased food intake, reduced physical activity and reduced 
metabolic rate, suggesting that these energy-conserving adaptations are at least partially 
mediated by the hypothalamus. 
 
1. Introduction 
 
Living organisms, from worms and flies to monkeys and human beings, show adaptive 
mechanisms in response to changes in food intake, body weight or adiposity that help to 
attenuate excessive deviations from optimum levels. This physiological drive to defend a ‘set 
point’ in body weight and adiposity helps to explain why obesity is so resistant to non-surgical 
treatments and – on the other hand – why many people gain weight slowly, if at all, despite 
large day to day variations in food intake and voluntary energy expenditure. However, 
whereas the current worldwide obesity epidemic would suggest that the adaptive 
mechanisms that prevent excessive weight gain during positive energy balance are easily 
overridden by inactivity and over consumption of readily accessible foods and beverages, the 
adaptive mechanisms that prevent weight gain below a certain threshold appear to be 
considerably more powerful. This is likely related to the fact that starvation is a more 
immediate threat to species survival than over nutrition. Indeed, whereas excessive weight 
loss or weight gain both threaten reproductive fitness and individual lives, starvation reduces 
fertility and kills in a matter of weeks to months whereas over consumption generally only 
hinders fertility once body mass index reaches the obese range, and it takes decades to die 
from the metabolic complications of obesity. 
 Multiple systems and mechanisms are involved in the critical process of preventing 
negative energy balance. For example, upon perception of energy deficit, adaptive changes 
in gut functions, in brain centers that regulate food hedonics and eating behavior, and in 
hypothalamic centers can collectively promote the restoration of energy balance. The 
pathways by which energy deficit is perceived by the organism involve signals from nutrients 
and hormones that converge and act directly on brain centers such as the hypothalamus, as 
recently reviewed (Sandoval et al., 2008 and Ahima and Lazar, 2008). Adaptive changes in 
gut function in response to negative energy balance include increased circulating 
concentrations of the ‘hunger hormone’ ghrelin (Olszanecka-Glinianowicz et al., 2008), and 
decreased circulating concentrations of the ‘satiety hormone’ peptide YY (PYY) (Pfluger et al., 
2007), and these changes could contribute to increased appetite. Additionally, negative 
energy balance has been reported to enhance food palatability (Cameron et al., 2008) and 
food hoarding behavior (Shizgal et al., 2001), demonstrating the diversity and complexity of 
adaptive responses that defend against energy deficiency. For the purposes of this review, 
however, we will concentrate on the adaptive mechanisms that attenuate weight loss during 
energy restriction in animals and humans, focusing on energy intake, energy expenditure due 
to basal metabolic rate and physical activity, and the role of the hypothalamus – particularly 
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the arcuate nucleus (ARC) – in mediating these processes. 
 In brief, energy restriction in animals and humans is associated with increases in food 
intake or appetite and reductions in resting or total daily energy expenditure beyond those 
that would be expected from the associated losses in body mass. These changes have been 
shown to contribute to weight regain. Additionally, some studies suggest that energy 
restriction reduces physical activity levels, and this may also contribute to weight regain given 
that physical activity is a major determinant in successful weight maintenance in weight-
reduced individuals. 
 Work in animals has shown that energy restriction leads to changes in expression of 
a variety of neuropeptides within the hypothalamus, and these changes likely contribute to the 
associated changes in food intake or appetite, energy expenditure and physical activity. 
Intriguingly, all of these energy-conserving adaptations have been shown to occur even in 
overweight and obese people after loss of as little as 6–12% of body weight (Doucet et al., 
2000, Westerterp-Plantenga et al., 2001, Martin et al., 2007, Leibel et al., 1995 and Hukshorn 
et al., 2003a) and may therefore contribute to the exceedingly low success rate of non-
surgical treatments for overweight and obesity. Understanding the hypothalamic mechanisms 
for the energy-conserving adaptations that occur in response to energy deficit is likely to lead 
to more effective treatments for overweight and obesity. 
 
2. Effects of energy deficit on hypothalamic regulators of energy balance 
 
By knowledge of the hypothalamic changes occurring with fasting or energy restriction in 
animals, and knowledge of how these hypothalamic changes influence energy homeostasis, 
substantial insights have been gained into the mechanisms by which the hypothalamus 
regulates body weight. There are dozens of neuropeptides whose hypothalamic expression 
has been shown to be altered by experimentally induced changes in energy balance and 
whose central administration results in short- or long-term changes in body weight or the 
parameters that influence it. Such factors include orexigenic signals such as galanin, melanin-
concentrating hormone, glutamate, γ-aminobutyric acid, hypocretins/orexins and the 
anorexigenic corticotropin-releasing hormone family of peptides and neurotensin (Kalra et al., 
1999). For the purposes of this review we will focus on the following factors within the ARC 
and their role in the regulation of food intake, energy expenditure and physical activity: the 
orexigenic agents neuropeptide Y (NPY), agouti related peptide (AgRP) and the opioid 
peptides dynorphins, as well as the anorexigenic agent proopiomelanocortin (POMC), the 
precursor of alpha-melanocyte stimulating hormone (α-MSH) and the co-expressed cocaine 
and amphetamine-regulated transcript (CART), as summarized in Fig. 1. 
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Fig. 1. The role of NPY/AgRP and POMC/CART in the ARC in the regulation of energy homeostasis. Under conditions of negative energy balance, expression of NPY and AgRP
in the ARC are increased while that of POMC and CART are reduced. Subsequently, enhanced action of NPY on Y receptors such as Y1 and Y5 in other hypothalamic nuclei,
notably the PVN, induces effects on food intake, physical activity and energy expenditure via multiple mechanisms involving the brain stem, the pituitary gland (e.g. the
hypothalamo-pituitary thyroid axis) and other brain nuclei. Additionally, enhanced AgRP antagonism of MC receptors, notably MC4 receptors, and reduced agonism of these
receptors by !-MSH, a product of the POMC gene, promotes orexigenic and energy-conserving effects via complex neuronal relays.
Vrang et al., 1999). CART has been shown to have anorexigenic as
well as orexigenic effects. Hypothalamic expression levels of both
POMC and CART are decreased during food deprivation in rodents
(Ziotopoulou et al., 2000; Swart et al., 2002; Brady et al., 1990;
Savontaus et al., 2002; Mizuno et al., 1999; Kristensen et al., 1998;
Ahima et al., 1999).
In summary, food deprivation alters the expression levels of
hypothalamic regulators of energy balance with an up-regulation
of orexigenic neuropeptides andadown-regulationof anorexigenic
neuropeptides. These changesmay be critical inmediating energy-
conserving mechanisms and enhancing survival during energy
deficit.
2.2. Insights from genetically obese rodents
In addition to short-term fasting studies in rodents, another line
of evidence that a particular hypothalamic peptide plays an impor-
tant role in the regulation of energy homeostasis is observation
that the hypothalamic expression of that peptide is altered in obese
rodentmodels. For this purpose, rodents that are deficient in leptin
or the action of leptin have been used extensively as a model of
chronic energy deficit with concurrent obesity.
Leptin is the hormone product of the mouse ob gene and
human homologue gene, LEP (Zhang et al., 1994). Leptin is secreted
predominantly by adipocytes and its expression is positively influ-
enced by the amount of energy stored in fat (Maffei et al., 1995;
Frederich et al., 1995; Considine et al., 1996; Hamilton et al., 1995;
Lönnqvist et al., 1995). The initial view of leptin as an anti-obesity
hormone (Friedman and Halaas, 1998; Flier, 1998; Spiegelman and
Flier, 1996) based on the observation that administration of lep-
tin to rodents decreases food intake, increases energy expenditure
and enhances lipid oxidation (Halaas et al., 1995; Pelleymounter
et al., 1995; Campfield et al., 1995; Shimabukuro et al., 1997) has
been challenged due to the inability of high levels of endogenous
or exogenous leptin to induce the same effects in obese patients
and other obese mammals (Maffei et al., 1995; Frederich et al.,
1995; Considine et al., 1996; Van Heek et al., 1997). On the other
hand, there is a significant decrease in circulating leptin levels
during energy deficit (Frederich et al., 1995; Ahima et al., 1996).
This fall in leptin with fasting has been demonstrated to be an
important mediator of the neuroendocrine adaptations to energy
restriction (Legradi et al., 1997, 1998; Yu et al., 1997; Finn et al.,
1998; Bray and York, 1979). Together with the leptin resistance
of obesity, it seems that the dominant role of leptin in energy
homeostasis is as a mediator of the adaptations to energy deficit
(Ahima et al., 1996; Bray and York, 1979; Ahima and Flier, 2000;
Jequier, 2002). Indeed, rodent models with leptin deficiency such
as ob/ob mice, or leptin receptor deficiency such as db/db mice or
fa/fa (Zucker) rats, have similar behavioral,metabolic and neuroen-
docrine abnormalities as those resulting from energy deficit such
as hyperphagia, hypometabolism and a variety of neuroendocrine
defects including infertility and profound hypercorticosteronemia
and are associated with early onset morbid obesity and diabetes
(Halaas et al., 1995; Campfield et al., 1995; Ahima et al., 1996; Bray
andYork, 1979). Thus leptin-deficient and leptin receptor-deficient
rodents are a model of chronic energy deficit with concomitant
obesity.
HypothalamicNPYgeneexpressionandsecretion isupregulated
inob/ob anddb/dbmiceand fa/fa rats (Wilding et al., 1993; Schwartz
et al., 1996; Beck, 2000; Sanacora et al., 1990; Kowalski et al., 1999).
In addition to changes in NPY expression and secretion, function-
ality of the NPY-ergic system is modified in rodents with deficient
leptin signaling. Thus the insulin-induced reduction in hypothala-
mic NPYmRNA expression seen in lean rats is abolished in fa/fa rats
(Schwartz et al., 1991).Moreover, NPY is released in an exacerbated
and anarchic manner in fa/fa rats (Stricker-Krongrad et al., 1997;
Dryden et al., 1995) rather than showing a peak release during
the transition from the light to the dark phase as in lean coun-
terparts (Jhanwar-Uniyal et al., 1990). This may contribute to the
disappearance of the rhythmof feeding behavior between dark and
light phases in fa/fa rats (Beck, 2000; Becker and Grinker, 1977).
Most significantly, the importance of NPY in mediating the syn-
drome associated with leptin deficiency is seen by attenuation of
the hyperphagia and the neuroendocreine defects and obesity of
ob/ob mice by NPY knockout (Erickson et al., 1996a; Marsh et al.,
1998).
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2.1. Insights from fasting in animals 
 
One line of evidence that a particular hypothalamic peptide plays a role in the regulation of 
energy homeostasis is the observation that energy restriction alters the hypothalamic 
expression of that peptide. The orexigenic NPY which acts via Y receptors and AgRP, which 
also induces orexigenic effects by antagonism of hypothalamic melanocortin (MC) receptors 
(Robinson et al., 2000), are co-expressed in neurons in the ARC (Chronwall et al., 1985, 
Broberger et al., 1998 and Hahn et al., 1998) as shown in Fig. 1. These NPY-AgRP neurons 
in the ARC give rise to projections towards the paraventricular nucleus (PVN) as well as the 
dorsomedial nucleus (DMN) of the hypothalamus and the median preoptic area (Bai et al., 
1985 and Kerkerian and Pelletier, 1986). During food deprivation in rodents, unanimous 
research shows that the hypothalamic peptide content and mRNA expression levels of both 
NPY (Ziotopoulou et al., 2000, Swart et al., 2002, Brady et al., 1990, Kalra et al., 
1991 and Savontaus et al., 2002) and AgRP (Ziotopoulou et al., 2000, Swart et al., 2002, 
Savontaus et al., 2002 and Mizuno and Mobbs, 1999) are increased. In addition to up-
regulation of hypothalamic expression of the orexigenic NPY and AgRP, energy restriction in 
rodents up-regulates the expression of pre-prodynorphin, an orexigenic member of the opioid 
peptide family (Berman et al., 1997 and Herve and Fellmann, 1997). As will be discussed 
below, these changes in hypothalamic expression of orexigenic agents can contribute to the 
appetite-promoting and energy-conserving effects of negative energy balance. 
 Whereas energy deficit up-regulates the hypothalamic expression of orexigenic 
peptides, it down-regulates that of anorexigenic agents. POMC in the ARC and the co-
expressed CART are two such examples, and these are illustrated in Fig. 1. POMC is the 
precursor of α-MSH, which decreases feeding by agonizing central MC4 receptors (Benoit et 
al., 2000, McMinn et al., 2000 and Vrang et al., 1999). CART has been shown to have 
anorexigenic as well as orexigenic effects. Hypothalamic expression levels of both POMC 
and CART are decreased during food deprivation in rodents (Ziotopoulou et al., 2000, Swart 
et al., 2002, Brady et al., 1990, Savontaus et al., 2002, Mizuno et al., 1999, Kristensen et al., 
1998 and Ahima et al., 1999). 
 In summary, food deprivation alters the expression levels of hypothalamic regulators 
of energy balance with an up-regulation of orexigenic neuropeptides and a down-regulation of 
anorexigenic neuropeptides. These changes may be critical in mediating energy-conserving 
mechanisms and enhancing survival during energy deficit. 
 
2.2. Insights from genetically obese rodents 
 
In addition to short-term fasting studies in rodents, another line of evidence that a particular 
hypothalamic peptide plays an important role in the regulation of energy homeostasis is 
observation that the hypothalamic expression of that peptide is altered in obese rodent 
models. For this purpose, rodents that are deficient in leptin or the action of leptin have been 
used extensively as a model of chronic energy deficit with concurrent obesity. 
 Leptin is the hormone product of the mouse ob gene and human homologue gene, 
LEP (Zhang et al., 1994). Leptin is secreted predominantly by adipocytes and its expression 
is positively influenced by the amount of energy stored in fat (Maffei et al., 1995, Frederich et 
al., 1995, Considine et al., 1996, Hamilton et al., 1995 and Lönnqvist et al., 1995). The initial 
view of leptin as an anti-obesity hormone (Friedman and Halaas, 1998, Flier, 
1998 and Spiegelman and Flier, 1996) based on the observation that administration of leptin 
to rodents decreases food intake, increases energy expenditure and enhances lipid oxidation 
(Halaas et al., 1995, Pelleymounter et al., 1995, Campfield et al., 1995 and Shimabukuro et 
al., 1997) has been challenged due to the inability of high levels of endogenous or exogenous 
leptin to induce the same effects in obese patients and other obese mammals (Maffei et al., 
1995, Frederich et al., 1995, Considine et al., 1996 and Van Heek et al., 1997). On the other 
hand, there is a significant decrease in circulating leptin levels during energy deficit (Frederich 
et al., 1995 and Ahima et al., 1996). This fall in leptin with fasting has been demonstrated to 
be an important mediator of the neuroendocrine adaptations to energy restriction (Legradi et 
al., 1997, Legradi et al., 1998, Yu et al., 1997, Finn et al., 1998 and Bray and York, 1979). 
Together with the leptin resistance of obesity, it seems that the dominant role of leptin in 
energy homeostasis is as a mediator of the adaptations to energy deficit (Ahima et al., 1996, 
Bray and York, 1979, Ahima and Flier, 2000 and Jequier, 2002). Indeed, rodent models with 
leptin deficiency such as ob/ob mice, or leptin receptor deficiency such as db/db mice or fa/fa 
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(Zucker) rats, have similar behavioral, metabolic and neuroendocrine abnormalities as those 
resulting from energy deficit such as hyperphagia, hypometabolism and a variety of 
neuroendocrine defects including infertility and profound hypercorticosteronemia and are 
associated with early onset morbid obesity and diabetes ( Halaas et al., 1995, Campfield et 
al., 1995, Ahima et al., 1996 and Bray and York, 1979). Thus leptin-deficient and leptin 
receptor-deficient rodents are a model of chronic energy deficit with concomitant obesity. 
 Hypothalamic NPY gene expression and secretion is upregulated in ob/ob and db/db 
mice and fa/fa rats ( Wilding et al., 1993, Schwartz et al., 1996, Beck, 2000, Sanacora et al., 
1990 and Kowalski et al., 1999). In addition to changes in NPY expression and secretion, 
functionality of the NPY-ergic system is modified in rodents with deficient leptin signaling. 
Thus the insulin-induced reduction in hypothalamic NPY mRNA expression seen in lean rats 
is abolished in fa/fa rats ( Schwartz et al., 1991). Moreover, NPY is released in an 
exacerbated and anarchic manner in fa/fa rats ( Stricker-Krongrad et al., 1997 and Dryden et 
al., 1995) rather than showing a peak release during the transition from the light to the dark 
phase as in lean counterparts (Jhanwar-Uniyal et al., 1990). This may contribute to the 
disappearance of the rhythm of feeding behavior between dark and light phases in fa/fa rats ( 
Beck, 2000 and Becker and Grinker, 1977). Most significantly, the importance of NPY in 
mediating the syndrome associated with leptin deficiency is seen by attenuation of the 
hyperphagia and the neuroendocreine defects and obesity of ob/ob mice by NPY knockout ( 
Erickson et al., 1996a and Marsh et al., 1998). 
 In addition to up-regulation of the hypothalamic NPY-ergic system in mice deficient in 
leptin signaling, hypothalamic expression of the orexigenic AgRP is increased five to ten fold 
in ob/ob and db/db mice ( Mizuno and Mobbs, 1999 and Shutter et al., 1997). Additional 
orexigenic peptides whose hypothalamic expression is up-regulated by leptin deficiency in 
ob/ob mice are endogenous opioids. The endogenous opioid system is composed of a family 
of three peptides; endorphins, enkephalins, and dynorphins, which act predominantly on mu 
(µ), delta (δ) and kappa (κ) opioid receptors, respectively ( Glass et al., 2000). Thus ob/ob 
mice have a 5-fold increase in dynorphin peptide level in the DMN and a 2–5-fold increase in 
β-endorphins in the DMN, PVN as well as the ventromedial nucleus of the hypothalamus 
(VMN) ( Khawaja et al., 1991). Additionally, ob/ob mice show a significant increase in 
sensitivity to κ-opioid receptor-preferring ligands with respect to glucoregulatory functions ( 
Khawaja et al., 1990). 
 Whereas the hypothalamic expression, secretion or function of orexigenic peptides is 
up-regulated by leptin deficiency in rodents, anorexigenic hypothalamic peptides are down-
regulated in rodents with leptin deficiency. Thus hypothalamic POMC and CART mRNA 
levels are 50% and 15% lower in ob/ob mice than in lean counterparts respectively ( Thornton 
et al., 1997, Schwartz et al., 1997, Mizuno et al., 1998 and Duan et al., 2007). 
 These data demonstrate that in rodent models of concomitant energy deficit and 
obesity due to deficiency in leptin signaling, the hypothalamus shows increased expression or 
secretion of orexigenic neuropeptides and decreased expression of anorexigenic 
neuropeptides. 
 
2.3. Insights from humans 
 
While it is not currently feasible to investigate hypothalamic expression or secretion of NPY, 
AgRP, opioids, POMC/α-MSH or CART in humans during dynamic changes in energy 
balance, existing data suggests that – as in animals – these hypothalamic peptides are 
involved in the regulation of energy homeostasis in humans. For instance, people with 
anorexia nervosa who are underweight and malnourished have been found to have 
significantly increased concentrations of NPY in the cerebrospinal fluid compared to normal 
weight controls, and this change is significantly correlated with the decrease in serum and 
cerebrospinal fluid leptin concentrations (Kaye et al., 1990, Martinez et al., 1993, Hebebrand 
et al., 1995, Grinspoon et al., 1996, Baranowska et al., 1997, Ferron et al., 
1997 and Mantzoros et al., 1997). Moreover, the elevated cerebrospinal fluid NPY levels in 
people with anorexia nervosa are normalized when their eating behavior and body weight are 
restored to normal, suggesting that increases in central NPY levels may be a biological 
adaptation to energy deficit in humans (Kaye et al., 1990 and Gendall et al., 1999) as well as 
in rodents. In keeping with this, a polymorphism in human preproNPY, a p.L7P substitution, 
has been shown to cause altered NPY secretion, and association studies suggest that this 
functional substitution may be a strong independent risk factor for various metabolic and 
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cardiovascular diseases (Pesonen, 2008). 
 Further evidence that the hypothalamic factors implicated in energy homeostasis in 
rodents are also important in humans comes from the fact that mutations in these genes in 
humans are linked to obesity. For instance, people who have compound heterozygous 
mutations in the POMC gene or the gene for the enzyme that converts POMC to α-MSH 
(proconvertase or PC1) are clearly obese (Clement, 2000). In addition, several dominant 
mutations in the MC4 receptor gene cause early onset obesity, and it is estimated that MC4 
receptor mutations may be a relatively common cause of excessive adiposity amongst people 
who are severely obese (Clement, 2000). Additionally, a CART missense mutation has been 
shown to co-segregate with severe obesity through three generations in a human family, and 
polymorphisms in the CART gene may influence fat distribution and are associated with 
obesity in humans (Murphy, 2005). 
 Taken together, these findings illustrate the important contribution of NPY, the 
melanocortin system and CART to energy homeostasis in humans. 
 
3. Effects of energy deficit and the resultant hypothalamic changes on appetite 
 
Energy deficit, or perceived energy deficit as in rodents lacking leptin signaling, are 
associated with changes in hypothalamic peptide expression as discussed in Section 2. One 
of the major pathways through which these hypothalamic changes promote positive energy 
balance is by stimulating food intake. Unanimous research shows that energy deficit, or the 
hypothalamic changes elicited by energy deficit, lead to robust increases in food intake or 
appetite in rodents and humans and that this change promotes weight regain. 
 
3.1. Effects of energy deficit on food intake in rodents 
 
Rodent studies have clearly shown that negative energy balance results in compensatory 
increases in food intake that promote weight regain. In lean mice, 48 h of food deprivation 
results in an 18% reduction in body weight and a 65% increase in daily food intake compared 
to that measured prior to fasting, and this fasting-induced hyperphagia persists for up to 5 
days (Erickson et al., 1996b). Not only is hyperphagia seen in lean animals after acute 
fasting, it also occurs in obese animals after less severe but longer-term energy restriction. In 
obesity-prone rats that were rendered obese by ad libitum access to a high fat diet, reducing 
energy intake to 43% of ad libitum intake for 2 weeks resulted in a 15% loss of body weight ( 
MacLean et al., 2004). However, when these rats were allowed ad libitum access to a low fat 
diet for 8 weeks, energy intake increased to levels measured on the high fat diet prior to 
weight reduction, and body weight returned towards the growth curve of age-matched 
obesity-prone rats that had continuous ad libitum access to the high fat diet ( MacLean et al., 
2004). Although weight reduction in these obese rats reduced energy expenditure and as 
such would tend to promote weight regain as described in Section 5.1, the major factor 
driving their weigh regain was increased energy intake, because weight-reduced obese rats 
that followed an energy restricted maintenance diet for 8 weeks maintained their lower weight 
(MacLean et al., 2004).Taken together, these data demonstrate the pivotal role of 
hyperphagia in restoring usual body weight after energy restriction in lean and obese rodents. 
 
3.2. Effects of energy deficit on appetite in humans 
 
As might be expected, severe energy restriction in lean people results in compensatory 
increases in food intake. In the Minnesota Experiment by Ancel Keys and colleagues, 24 
weeks of semi-starvation resulting in a 25% reduction in body weight in lean young men lead 
to a 160% increase in energy intake relative to pre-starvation intake (Keys et al., 1950). 
Similar findings have been shown after short-term energy restriction. In the two days after 
48 h on a restricted diet consisting of 38% of their estimated maintenance energy 
requirements and resulting in a 1.1 kg weight loss, lean young men ate 143% and 124% of 
their estimated energy requirements each day, respectively (Mars et al., 2005). Even in 
overweight people, losing weight by severely restricting energy intake increases measures of 
appetite such as hunger, desire to eat and estimates of prospective consumption (Mars et al., 
2005 and Hukshorn et al., 2003b). While it is often assumed that hunger is only a problem 
associated with very low energy diets or ‘crash dieting’, or with energy restriction in lean 
individuals, significant increases in appetite or hunger have also been measured in obese 
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people losing weight by mild energy restriction, or by mild energy restriction combined with 
physical activity (Doucet et al., 2000 and Westerterp-Plantenga et al., 2001). This increased 
appetite probably contributes to the high rate of attrition of weight loss attempts, since the 
degree of hunger experienced by overweight people after an energy restricted diet is a 
significant predictor of subsequent weight regain (Pasman et al., 1999). 
 
3.3. Effects of hypothalamic regulators of energy balance on food intake 
 
The effects of energy restriction on food intake or appetite can be recapitulated in sated 
animals by experimentally mimicking the associated hypothalamic changes. This therefore 
suggests that it is these hypothalamic changes that contribute to the hyperphagia or 
increased appetite in response to restricted food intake. For instance, the orexigenic agents 
NPY (Stanley et al., 1986), AgRP or synthetic MC4 receptor antagonists (Hagan et al., 2000, 
Kim et al., 2000a and Kask et al., 1999) increase body weight and/or fat mass and feeding. In 
addition to these orexigenic effects of NPY and AgRP, endogenous opioids may also 
contribute to the energy-conserving, appetite-promoting effects of negative energy balance. 
Administration of opioid receptor agonists to animals (and humans) results in robust and 
sustained increases in food intake and body weight, whereas opioid receptor antagonists 
have the opposite effect (Glass et al., 2000). The dynorphins and their κ-opioid receptors are 
strongly implicated in the effects of opioids on feeding and body weight. Indeed, selective 
blockade of κ-opioid receptors significantly reduces fasting-induced hyperphagia in rats 
(Lambert et al., 1993), and reduces food intake and body weight in obese rodents models 
(Cole et al., 1995 and Jarosz and Metzger, 2002). 
 In comparison to the hyperphagic effects of NPY, AgRP and opioids such as 
dynorphins, hypothalamic administration of the anorexic peptides α-MSH or analogs (Thiele 
et al., 1998 and Brown et al., 1998) or CART-related peptides (Kristensen et al., 1998, 
Murphy, 2005 and Larsen et al., 2000) to rodents reduce body weight and/or fat mass in 
association with inhibition of food intake. Interestingly, the studies in which CART was shown 
to have an anorexigenic or weight-reducing effect in fed or 24-h fasted rodents used the 
intracerebroventricular route of administration (Murphy, 2005), but this was shown to induce 
behavioral defects that could interfere with food intake (Abbott et al., 2001). Contrarily, recent 
studies have shown that administering minute doses of CART directly into specific 
hypothalamic nuclei such as the ARC and PVN of 24-h fasted rats increases food intake 
without inducing the behavioral abnormalities seen after intracerebroventricular administration 
(Abbott et al., 2001). Moreover, long-term overexpression of CART in the PVN of normal rats 
using an adeno-associated virus expressing CART increased food intake and body weight, 
particularly under high fat-fed conditions (Smith et al., 2008). It is therefore likely that CART 
has dual effects on food intake and energy balance depending on the brain region in which it 
acts and the behavioral alterations it may induce. 
 The effects of these agents on body weight and/or adiposity are not simply due to the 
associated changes in food intake, but can also be ascribed to changes in energy efficiency. 
Indeed, when the food intake of animals that receive hypothalamic administration of these 
agents is matched in control animals (i.e. the food intake of infused animals is restricted to 
that consumed by controls, or the food intake of control rats is restricted to the intake of 
infused animals), the effects to promote changes in energy balance or adiposity persist 
(Zarjevski et al., 1993, Small et al., 2001, Cettour-Rose and Rohner-Jeanrenaud, 
2002 and Rohner-Jeanrenaud, 1995). Clearly, therefore, changes in food intake alone do not 
fully account for the associated changes in body weight or fat mass, and hypothalamic 
peptides have additional effects besides alterations in food intake. 
 
4. Effects of energy deficit and the resultant hypothalamic changes on physical activity 
 
Although increased food intake is an important mediator of weight gain after periods of energy 
deficit or during hypothalamic manipulations that mimic energy deficiency, it is not the only 
mechanism promoting positive energy balance. Studies in which hypothalamic manipulations 
that mimic energy deficiency result in decreased physical activity suggest that reduced 
physical activity could contribute to the tendency to conserve energy during periods of 
negative energy balance. Some studies show that energy deficiency reduces physical activity 
in animals and humans, but this has not been extensively studied nor is it a universally 
observed phenomenon. 
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4.1. Effects of energy deficit on physical activity in rodents 
 
Studies on the effects of 48–72-h fasting on physical activity in rodents have given conflicting 
results, indicating increased (Overton et al., 2001), decreased (Williams et al., 2000) or no 
change in physical activity (Nagashima et al., 2003). During long-term chronic food restriction 
in rodents however, an increase in physical activity is generally observed. Using an electronic 
device attached to the home cage, increased physical activity was reported in aged and 
chronically energy restricted male and female rats compared to age- and gender-matched ad 
libitum fed controls ( Duffy et al., 1989 and Duffy et al., 1990a). Similar results were obtained 
in mice (Duffy et al., 1990b). Longitudinal analysis of home cage activity showed that the age-
related decline in physical activity in ad libitum fed rats was prevented by chronic energy 
restriction ( Yu et al., 1985). Moreover, when access to a running wheel was given, 
chronically food-restricted rats and mice showed higher levels of wheel running activity than 
ad libitum fed control animals ( Goodrick et al., 1983a and Ingram et al., 1987). In fact, under 
certain experimental conditions, rats that are given access to food for a limited period of time 
each day as well as free access to a running wheel actually run so much that they die of 
starvation (Gutierrez et al., 2002). Interestingly, intermittent food restriction differentially 
affected wheel running activity across the life span in male rats (Goodrick et al., 1983b). Thus 
wheel running activity was lower in the energy restricted group early in life but was higher in 
the same group later in life compared to ad libitum fed age-matched controls ( Goodrick et al., 
1983b), suggesting that the influence of energy deficit on physical activity may change with 
ageing. A similar outcome was seen in young and old non-human primates as will be 
discussed below. Age differences may explain some of the discrepancies in results between 
studies showing no change or a decrease in physical activity compared to ad libitum fed 
controls ( Evans et al., 2005 and Dulloo and Girardier, 1993). Taken together, the most 
consistent finding in rodents is that physical activity increases during long-term energy deficit. 
It is not yet clear why this is so, but in some paradigms increased physical activity in the face 
of energy restriction may be related to increased food-seeking behavior; in other paradigms it 
may be related to maintenance of body temperature in the face of the energy deficit-induced 
reduction in body temperature (Gutierrez et al., 2002). 
 
4.2. Effects of energy deficit on physical activity in humans and non-human primates 
 
Reports on the effects of energy deficit on physical activity in humans are sparse and there 
are difficulties in accurately assessing physical activity in free-living conditions. Moreover, 
spontaneous physical activity levels measured in metabolic chambers have little correlation 
with free-living physical activity levels as indicated by the ratio of total energy expenditure 
measured by double-labeled water versus basal metabolic rate (Martin et al., 2007). Using 
this technique, 25% energy deficit in overweight men and women induced by food restriction 
for 3 months was shown to reduce free-living physical activity levels (Martin et al., 2007). In 
another study, however, overweight subjects on a diet-only intervention to achieve weight 
loss of over 10 kg and a body mass index of under 25 kg/m2 showed reduced physiological 
stress in response to exercise and a tendency to be more physically active than they had 
been prior to the intervention (Weinsier et al., 2000a). It is important to note, however, that in 
the study reporting reduced free-living physical activity in response to energy deficit, subjects 
were studied while in energy deficit (Martin et al., 2007). Contrarily, in the study reporting 
improvements in exercise response and activity levels, subjects were studied after a period of 
4 weeks in energy balance (Weinsier et al., 2000a). Given that certain energy-conserving 
adaptations to energy deficit, notably reduced metabolic rate and thyroid function, are seen 
during energy restriction but not after a period of 10 days to 3 months in energy balance in 
weight-reduced individuals (Weinsier et al., 2000b and Westerterp-Plantenga et al., 2004), 
this difference in testing schedule probably contributes to the discrepancy in findings, in 
addition to other differences such as the method used to determine free-living physical 
activity. In order to determine whether energy deficit per se has effects on physical activity in 
humans independently of the effect of weight reduction to improve mobility, it is necessary to 
investigate subjects while they are still in a state of negative energy balance. 
 There are a few studies that have investigated the effects of long-term energy 
restriction on physical activity in non-human primates. The results are variable. Adult rhesus 
moneys (9–10 years of age) submitted to 70% energy restriction for 1 year showed significant 
reductions in body weight, body fat and physical activity levels compared to ad libitum fed 
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controls ( Kemnitz et al., 1993). When energy restriction in adult monkeys was prolonged for 
5–6 years, however, no difference in physical activity (Ramsey et al., 1997), or a trend to 
increased physical activity (Moscrip et al., 2000), was reported. Similarly, a comparable 
(Moscrip et al., 2000) or increased (DeLany et al., 1999) level of physical activity was 
reported in old monkeys (17–22 years of age) who had been on an energy restricted diet for 
5–10 years compared to ad libitum fed controls. Given that adaptive energy-conserving 
responses to energy deficit can be temporary as discussed above ( Weinsier et al., 
2000b and Westerterp-Plantenga et al., 2004), differences in the timing of measurements in 
these non-human primate studies may account for these discrepancies. Nevertheless, energy 
restriction in young monkeys (i.e. 2–2.5 years of age) for 5–6 years consistently reduced 
physical activity ( Weed et al., 1997 and Moscrip et al., 2000), similar to the results seen in 
young versus old rodents (Goodrick et al., 1983a). 
 Taken together, a limited number of studies have shown that energy restriction is 
associated with reduced physical activity in young rodents and in young non-human primates, 
as well as in one study in overweight men and women in which physical activity was 
measured during energy restriction. This may represent an energy-conserving adaptation to 
reduced energy availability, in keeping with the effects of hypothalamic regulators of energy 
homeostasis such as NPY, MC4 receptor action and CART on physical activity as discussed 
below. Contrarily, other studies have shown that energy restriction or weight loss in rodents, 
non-human primates and humans is associated with no change or an increase in physical 
activity. This may represent increased activity due to food-seeking behavior, maintenance of 
thermoregulation or increased mobility due to weight loss. Given that any effects of energy 
deficit on physical activity, if present, may be transient (Weinsier et al., 
2000b and Westerterp-Plantenga et al., 2004), physical activity needs to be measured during 
energy deficit in order to determine whether there is any effect of energy deficit per se on 
physical activity levels. 
 
4.3. Effects of hypothalamic regulators of energy balance on physical activity 
 
Reductions in physical activity in response to energy deficit, where present, could be 
mediated by the effects of energy deficit on hypothalamic peptides. It is well established that 
spontaneously genetically obese rodents, which demonstrate increased hypothalamic 
expression of NPY and AgRP (Shutter et al., 1997 and Makimura et al., 2000) concomitant 
with decreased expression of POMC and CART (Kristensen et al., 1998 and Makimura et al., 
2000) exhibit reduced physical activity compared to lean control animals (Butler and Cone, 
2001). Moreover, intracerebroventricular administration of NPY (Heilig et al., 1989), or MC4 
receptor knockout in rodents (Ste Marie et al., 2000) have been shown to reduce locomotion. 
In contrast, CART (Kimmel et al., 2000) has been shown to increase locomotor activity after 
infusion into the cerebral ventricles of rats, but these findings must be interpreted in light of 
the finding that intracerebroventricular but not intrahypothalamic administration of CART 
induces behavioral abnormalities that can impact on food intake and physical activity (Abbott 
et al., 2001). 
 
5. Effects of energy deficit and the resultant hypothalamic changes on energy 
expenditure 
 
Longer-term non-surgical clinical weight loss trials typically result in weight losses of 5–
14 kg/year, and most of that weight loss is achieved within the first months despite efforts to 
ensure volunteers’ compliance with physical activity and/or dietary prescriptions. While lack of 
compliance with lifestyle prescriptions is commonly recognized in clinical weight loss trials 
(perhaps related to the effects of energy deficit to increase appetite and reduce physical 
activity), the universality of the weight loss ‘plateau’ even in tightly controlled clinical research 
settings suggests metabolic factors preventing further weight loss. Indeed, studies from 
rodents and humans show that energy restriction and weight loss lead to marked and 
significant decreases in metabolic rate and energy expenditure. This energy-conserving 
adaptation is a significant predictor of subsequent weight regain in weight-reduced rodents 
(MacLean et al., 2004 and Dulloo and Girardier, 1990) and people (Pasman et al., 
1999 and Goran, 2000). Rodent studies suggest that this adaptation is mediated by the 
hypothalamic changes that occur in response to energy deficit. 
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5.1. Effects of energy deficit on energy expenditure in rodents 
 
In animals, energy expenditure has been estimated by parameters such as oxygen 
consumption, heat production, body temperature or expression of uncoupling proteins in 
muscle or fat. An acute 24-h fast that resulted in an approximately 25% reduction in body 
weight in mice reduced resting metabolic rate by 49% compared to that measured in mice 
allowed to eat ad libitum ( Bezaire et al., 2001). Similarly in rats, a 48–72-h period of food 
deprivation induced a 10–15% reduction in body weight and a significant reduction in 24-h 
oxygen consumption and light-phase core body temperature compared to that measured prior 
to fasting ( Williams et al., 2000, Nagashima et al., 2003 and Bezaire et al., 2001). 
Importantly, this reduction in oxygen consumption during food deprivation is largely 
independent of concurrent changes in locomotor activity, suggesting a reduction in resting 
metabolic rate due to negative energy balance per se ( Nagashima et al., 2003). In addition to 
marked effects of acute energy restriction in rodents, reduced energy expenditure also occurs 
during longer-term energy restriction. In lean rats, chronic energy restriction for several 
months that resulted in a 40% decrease in body fat mass gave rise to an 8% decrease in 
daily energy expenditure that could not be accounted for by changes in metabolic tissue mass 
or physical activity (Dulloo and Girardier, 1993). In obesity-prone rats, where marked obesity 
was induced by 16 weeks on a high fat diet, 60% energy restriction for 2 weeks resulting in a 
14% weight loss was accompanied by significantly suppressed energy expenditure ( 
MacLean et al., 2004 and MacLean et al., 2006). This decrease in energy expenditure in 
energy restricted rats remained significant compared to that in rats with continuous ad libitum 
access to food even after adjustment for changes in body composition ( MacLean et al., 
2004 and MacLean et al., 2006), suggesting an increased metabolic efficiency/decreased 
metabolic rate during negative energy balance. Interestingly, the reduced metabolic rate 
observed in these dietary-induced obese rats persisted throughout a period of weight 
maintenance for 8 weeks, thus restricted energy intake was required to achieve weight 
maintenance ( MacLean et al., 2004 and Dulloo and Calokatisa, 1991). This elevated energy 
efficiency contributed to rapid weight regain in these obesity-prone animals when ad libitum 
access to food was resumed ( MacLean et al., 2004 and Dulloo and Girardier, 1990). Take 
together, these studies demonstrate that acute or longer-term energy deficit lead to adaptive 
decreases in energy expenditure or metabolic rate in lean or obesity-prone rodents that are 
beyond the changes that would be expected from changes in locomotion or body mass. This 
metabolic adaptation predisposes towards weight restoration after energy restriction in 
rodents. 
 
5.2. Effects of energy deficit on energy expenditure in humans 
 
In accordance with studies in rodents, severe energy restriction in lean people results in 
compensatory reductions in metabolic rate. In the Minnesota Experiment by Ancel Keys et al, 
24 weeks of semi-starvation resulting in a 25% reduction in body weight in lean young men 
lead to 25% decrease in metabolic rate relative to pre-starvation intake (Keys et al., 1950). 
Reductions in energy expenditure or metabolic rate have also been observed in overweight or 
obese people after weight loss and when measured during negative energy balance. For 
instance, overweight women showed a drop in absolute resting metabolic rate of 840 kJ/day 
(200 kcal/day) after having reduced their weight to normal (Weinsier et al., 2000b). Although 
part of the observed decrease in metabolic rate was due to the lower energy cost of a smaller 
body size, the reduction was significant even after adjusting for fat free mass and fat mass 
(Weinsier et al., 2000b). Similarly, severely obese men and women showed 10–30% 
decreases in resting energy expenditure, total 24-h energy expenditure and non-resting 
energy expenditure (adjusted for fat free mass) after losing 10% of their body weight by a 
very low energy diet (Rosenbaum et al., 1997). After losing an additional 10% of their body 
weight, these decreases were even more pronounced (Rosenbaum et al., 1997) and 
accounted for a drop in total energy expenditure of 3700 kJ/day (890 kcal/day) (Leibel et al., 
1995). Similar reductions in resting metabolic rate or total energy expenditure have been 
observed in other studies in overweight or obese people after weight loss (Westerterp-
Plantenga et al., 2001, Martin et al., 2007, Hukshorn et al., 2003b, Westerterp-Plantenga et 
al., 2004 and Menozzi et al., 2000). This weight loss-induced drop in energy expenditure – 
like the associated increase in appetite – is a significant predictor of subsequent weight 
regain (Pasman et al., 1999 and Goran, 2000). 
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 It's important to note that not all clinical studies that have investigated energy 
expenditure in people after weight reduction have shown significant reductions in metabolic 
rate or energy expenditure beyond that which would be expected from the associated 
reduction in body mass. For instance, an average weight loss of 12.8 kg in black and white 
women, achieved through diet without exercise, was associated with reductions in sleeping 
and resting energy expenditures that were entirely attributable to changes in body 
composition (Weinsier et al., 2000a). Additionally, when post-obese men and women were 
studied after loss of 23–139 kg, 24-h energy expenditure and sleeping metabolic rate – when 
adjusted for body mass – were at least as high as in matched controls who had never been 
obese (Larson et al., 1995). In both of these studies, however, subjects were studied at 4 
weeks (Weinsier et al., 2000a) or between 2 months to 6 years (Larson et al., 1995) after 
weight loss. Moreover, it has been shown that whereas weight loss in overweight men or 
women results in reductions in resting metabolic rate adjusted for body composition when 
these parameters are measured while subjects are still in negative energy balance, this 
difference is no longer observed when subjects are studied again after 10 days (Weinsier et 
al., 2000b) or 3 months in energy balance (Westerterp-Plantenga et al., 2004). This ‘reversal’ 
phenomenon was not seen in obese men and women after a period of 2 weeks of weight 
maintenance after loss of 10% of their body weight (Rosenbaum et al., 2000 and Weinsier et 
al., 2001). Nonetheless, conclusions as to whether or not particular study populations of 
overweight or obese individuals show adaptive changes in metabolic rate or energy 
expenditure in response to weight loss need to make clear distinctions between 
measurements made in people during negative energy balance versus measurements made 
in people who have been in weight maintenance for a period of time. 
 In brief, energy deficit, whether short-term or longer-term, in rodents or in humans, in 
lean or obese individuals, reliably reduces indices of metabolic rate or energy expenditure 
even after adjusting for changes in body composition. In those clinical studies where weight 
loss was not associated with reductions in metabolic rate or energy expenditure, the 
discrepancy is likely due to the fact that subjects were studied at several days to years after 
weight loss, whereas the reduction in metabolic rate with weight loss in humans has been 
shown in some but not all human studies to be transient. 
 
5.3. Effects of hypothalamic regulators of energy balance on energy expenditure 
 
A large body of rodent studies have shown that changes in the central expression of 
hypothalamic regulators of energy homeostasis result in changes in energy expenditure as 
indicated by alterations in oxygen consumption, heat production, body temperature or 
expression of uncoupling proteins in muscle or fat. Notably, the orexigenic peptides NPY or 
AgRP (or MC4 receptor antagonism) not only increase food intake but also reduce 
parameters related to energy expenditure. Intracerebroventricular or intrahypothalamic NPY 
administration decreases core temperature (Szreder et al., 1994 and Currie and Coscina, 
1995) and reduces oxygen consumption (Hwa et al., 1999). Central NPY administration 
decreases sympathetically mediated thermogenic activity in brown adipose tissue (Kotz et al., 
1998 and Egawa et al., 1991), most likely by decreasing the expression of uncoupling protein-
1 (Kotz et al., 1998). MC4 receptor inactivation has similar effects to NPY on energy 
expenditure: MC4 receptor knockout mice exhibit significant reductions in oxygen 
consumption (Ste Marie et al., 2000), and intracerebroventricular administration of AgRP or 
MC4 receptor antagonists to rats decrease the mRNA and peptide levels of uncoupling 
protein 1 in brown adipose tissue (Small et al., 2001 and Baran et al., 2002). 
 In contrast to the effects of the orexigenic peptides NPY and AgRP to inhibit energy 
expenditure, the anorexigenic agent α-MSH appears to increase energy expenditure. Central 
administration of the α-MSH analogue MTII increased body temperature (Murphy et al., 
2000), oxygen consumption (Hamilton and Doods, 2002), as well as expression of uncoupling 
proteins in brown adipose tissue and muscle relative to control values (Cettour-Rose and 
Rohner-Jeanrenaud, 2002). The effects of CART on metabolic rate are not yet clear. Most 
studies would suggest a decreased metabolic efficiency after intrahypothalamic or 
intracerebroventricular CART administration to normal or obese rats, indicated by increased 
expression of uncoupling proteins 1, 2, and 3 in brown and white adipose tissue or muscle 
(Wang et al., 2000), increased lipid oxidation (Rohner-Jeanrenaud et al., 2002), a higher 
thermogenic response to a β3 agonist, increased uncoupling protein-1 mRNA expression in 
brown adipose tissue and significantly greater weight loss in response to 24-h fasting (Kong 
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et al., 2003). Another study, however, has suggested that intracerebroventricular CART 
administration reduces metabolic rate, as indicated by a decrease in oxygen consumption 
(Asakawa et al., 2001), but this effect may be related to the fact that CART, particularly in 
higher doses and when administered intracerebroventricular but not intrahypothalamically, 
induces motor disturbances (Larsen et al., 2000 and Abbott et al., 2001) which could inhibit 
food intake, physical activity and metabolic rate. 
 One mechanism via which changes in expression of hypothalamic regulators of 
energy homeostasis may reduce energy expenditure during energy deficit is through reduced 
thyroid function. Indeed, during energy deficit thyroid function is inhibited at multiple levels of 
the hypothalamo-pituitary-thyroid axis in rodents (Ahima et al., 1996, Blake et al., 1992, 
Boelen et al., 2006 and Gavin et al., 1980), in healthy men and women (Boelen et al., 2008), 
as well as in overweight or obese individuals (Hukshorn et al., 2003a, Weinsier et al., 2000b, 
Rosenbaum et al., 2000, Wadden et al., 1990, Naslund et al., 2000 and Douyon and 
Schteingart, 2002). As thyroid function is a major positive regulator of energy expenditure, 
this change could contribute to reduce energy expenditure during energy deficit. Enhanced 
hypothalamic expression of the orexigenic NPY and AgRP with energy deficiency likely 
inhibits the thyroid axis, because central administration of NPY, AgRP or MC4 receptor 
antagonists to normal rodents significantly reduces function of the thyrotropic axis at several 
levels (Small et al., 2001, Fekete et al., 2001 and Kim et al., 2000b). Neuronal endings 
containing NPY- and AgRP-immunoreactivity have been detected in close association with 
the thyrotropin releasing hormone-synthesizing neurons of the hypothalamic paraventricular 
nucleus in rodents (Legradi and Lechan, 1999 and Legradi and Lechan, 1998) and in man 
(Mihaly et al., 2000), suggesting direct inhibitory effects of NPY and AgRP on the thyrotropic 
axis at the level of the hypothalamus. 
 In summary, up-regulation in hypothalamic expression of the orexigenic peptides 
NPY and AgRP with energy deficit or in leptin-deficient obesity syndromes in rodents could 
induce metabolic changes consistent with reduced energy expenditure. Conversely, the 
anorexigenic agent POMC/α-MSH and the co-expressed CART induce metabolic changes 
consistent with increased energy expenditure after intracerebroventricular or 
intrahypothalamic administration, so the reductions in hypothalamic expression of these 
agents with energy deficit or leptin deficiency would also be expected to promote a 
hypometabolic state. These hypothalamic effects on energy expenditure may be mediated via 
changes such as reductions in activity of the hypothalamo-pituitary-thyroid axis, and could 
contribute to the inefficiency in weight loss that has been reported during longer-term 
negative energy deficit – particularly more extreme energy deficit – in obese humans 
(Sweeney et al., 1993). 
 
6. Summary and conclusions 
 
Although obesity is associated with a significantly greater risk of diseases such as diabetes, 
and although weight loss is associated with significant reductions in disease risk factors, most 
people who lose excess weight by lifestyle means regain the weight they lost. 
 A possible explanation for the attrition in weight loss attempts is that the body – even 
in obesity – defends against negative energy balance with compensatory mechanisms that 
protect against further weight loss. Energy deficit – whether acute or long-term, in rodents or 
in humans, in lean or in obese individuals – stimulates food intake or appetite and reduces 
metabolic rate or energy expenditure. These changes have been shown to contribute to 
weight regain in lean or post-obese animals and humans. Some but not all studies have 
shown that the reduction in metabolic rate that occurs in response to energy deficit in 
overweight or obese humans is transient, and this must be taken into consideration when 
making conclusions as to whether or not a particular study group exhibits compensatory 
reductions in metabolic rate or energy expenditure in response to energy deficit or weight loss 
that would predispose to weight regain. 
 In addition to effects on energy intake and metabolic rate or energy expenditure, a 
limited number of studies have shown that energy restriction is associated with reduced 
physical activity in young rodents and in young non-human primates, as well as in one study 
in overweight men and women in which physical activity was measured during energy 
restriction. This may represent an energy-conserving adaptation to reduced energy 
availability. Contrarily, other studies have shown that energy restriction or weight loss in 
rodents, non-human primates and humans is associated with no change or an increase in 
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physical activity. The reasons for this are not clear, but may involve increased activity due to 
food-seeking behavior, thermoregulation or increased mobility due to weight loss. Given that 
any effects of energy deficit on physical activity, if present, may be transient, physical activity 
needs to be measured during energy deficit in order to determine whether there is any effect 
of energy deficit per se on physical activity levels. 
 In the ARC, energy restriction up-regulates hypothalamic expression of the orexigenic 
NPY, AgRP and opioids such as dynorphins and down-regulates that of the anorexigenic α-
MSH or its precursor POMC and the co-expressed CART. Experimentally recapitulating these 
hypothalamic changes in fed animals or in rodents deficient in leptin or leptin receptors has 
been shown to mimic the increased food intake, reduced physical activity and reduced 
metabolic rate that have been observed during energy deficit. Taken together, these data 
suggest that the energy-conserving adaptations to energy deficit are mediated – at least in 
part – by the hypothalamus. 
 Given that longer-term non-surgical clinical weight loss trials typically result in weight 
losses of 5–14 kg/year and that most of that weight loss is achieved within the first months 
despite efforts to ensure volunteers’ compliance with physical activity and/or dietary 
prescriptions, and given the proven role of increased appetite and reduced metabolic in 
weight regain and the importance of physical activity for weight maintenance, targeting the 
hypothalamic pathways that stimulate appetite and reduce physical activity and metabolic rate 
during energy deficit – when combined with diet and exercise – would lead to better 
treatments for obesity. 
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